Analysis improves peak identification in data-independent acquisition proteomics, indicating software tools can achieve better reproducibility.
The peptide-centric strategy is widely applied in data-independent acquisition (DIA) proteomics to analyze multiplexed MS2 spectra. However, current software tools often rely on single-run data for peptide peak identification, leading to inconsistent quantification across heterogeneous datasets. Match-between-runs (MBR) algorithms address this by aligning peaks or elution profiles post-analysis, but they are often ad hoc and lack statistical frameworks for controlling peak quality, causing false positives and reduced quantitative reproducibility. Here we present DreamDIAlignR, a cross-run peptide-centric tool that integrates peptide elution behavior across runs with a deep learning peak identifier and alignment algorithm for consistent peak picking and FDR-controlled scoring. DreamDIAlignR outperformed state-of-the-art MBR methods, identifying up to 21.2% more quantitatively changing proteins in a benchmark dataset and 36.6% more in a cancer dataset. Additionally, DreamDIAlignR establishes an improved methodology for performing MBR compatible with existing DIA analysis tools, thereby enhancing the overall quality of DIA analysis.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: